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Abstract
Background Staphylococcus aureus (SA) and Coagulase-
negative staphylococci (CoNS) are often responsible for
infections of total hip arthroplasty (THA) and total knee
arthroplasty (TKA). One of the main differences between
these two microorganisms is their virulence, with SA pre-
sumed to be more virulent; however, few studies have
specifically investigated the impact of this virulence. This
inspired us to carry out a retrospective study to evaluate
whether the healing rate differed between SA and CoNS
infections.
Hypothesis We hypothesised that the healing rate is lower
for SA prosthetic joint infections.
Materials and methods This was a retrospective study of
101 consecutive Staphylococcus infection cases that
occurred between 2007 and 2011. There were 56 men and
45 women with an average age of 69 years (range 23–95).
The infection was associated with TKA in 38 cases and
THA in 63 cases. Thirty-two percent of patients had one or
more comorbidities with infectious potential. In our cohort,
there were 32 SA infections (31.7 %) and 69 CoNS
infections (68.3 %) with 58 of the infections being
methicillin-resistant (15 SA and 43 CoNS); there were 27
polymicrobial infections (26.7 %).
Results With a minimum 24-month follow-up after the end
of antibiotic treatment, the healing rate was 70.3 % overall
(71 patients). The healing rate was 75 % in the SA group
(24 patients) versus 68.1 % (47 patients) in the CoNS
group (P = 0.42).
Conclusion Our hypothesis was not confirmed: the healing
rate of SA prosthetic joint infections was not lower than
that of CoNS infections.
Level of evidence III, retrospective case–control study.
Keywords Periprosthetic joint infection  Staphylococcus
spp.  Total knee arthroplasty  Total hip arthroplasty
Introduction
The healing rate for periprosthetic joint infections (PJIs)
following total hip arthroplasty (THA) and total knee
arthroplasty (TKA) ranges from 26 to 100 %, depending on
the study and type of treatment [1–9]. Staphylococcus is
often found in PJIs [10], with Staphylococcus aureus (SA)
and coagulate-negative Staphylococci (CoNS) each being
implicated in about 25 % of infections [11–13].
Staphylococcus aureus has a higher intrinsic virulence
than CoNS [14, 15], but no published studies have
specifically compared the healing rates after PJI caused
by these two microorganisms. Parvizi et al. [1] found no
difference between them when the healing rate of
methicillin-resistant Staphylococcus infections was
compared. However, this was a controversial, under-
powered study, in which multiple treatment methods
(lavage–debridement, prosthesis change, etc.) were used.
Published data cannot be used to conclude that a dif-
ference exists between the outcome of PJIs caused by
SA or CoNS.
This encouraged us to carry out a study to determine
whether the healing rate after PJI differed between SA and
CoNS infection after a minimum follow-up of 2 years. We
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hypothesised that because SA is more virulent than CoNS,
the healing rate of PJIs due to SA would be lower than that
of PJIs due to CoNS.
Materials and methods
Patients
This continuous, retrospective study included all the cases
of primary THA or TKA septic revision (single- or two-
stage revision) due to Staphylococcus infection performed
between January 2007 and December 2011 at the Refer-
ence centre for complex joint infections in the greater
south-western area of France (CRIOAC-GSO). Patients
who had already undergone a surgical procedure before our
treatment (lavage, prosthesis change) and those who were
treated conservatively (lavage with synovectomy, sup-
pressive antibiotic therapy) were excluded. If no preoper-
ative microbiology results were available, empirical
intravenous dual antibiotic treatment (vancomycin ? third-
generation cephalosporin) was initiated immediately after
the intraoperative samples had been collected. When pos-
sible, the treatment was shifted after the first week to oral
antibiotics adapted to the microorganism identified and its
resistance, for a minimum of 45 days. If preoperative joint
aspiration was performed and provided useful information,
the antibiotics were adapted to the microorganism identi-
fied and its resistance.
Among the 245 surgical revision procedures for PJI per-
formed during this period, 101 were due to Staphylococcus
infection. Patients with intraoperative samples positive for
both SA and CoNS were excluded. The cohort consisted of
56 men and 45 women with an average age of 69 years
(range 23–95). There were 63 THA infections and 38 TKA
infections. These were treated by single-stage revision in 40
cases (32 THA and 8 TKA) and two-stage revision in 61
cases (31 THA and 30 TKA). A two-stage procedure was
carried out if a resistant bacterium was identified, a polymi-
crobial infection was present, or a fistula was identified.
Using the criteria outlined by Joulie et al. [9], it was deter-
mined that 32 % of patients had one or more comorbidities
with infectious potential. The 32 SA infections (31.7 %) and
69 CoNS infections (68.3 %) are described in detail in
Table 1. The Staphylococcus was methicillin-resistant in 58
cases (15 SA, 43 CoNS). Among these infections, 27 were
polymicrobial (multiple bacteria species): 12 in the SA group
and 15 in the CoNS group. The two groups were comparable
in age, sex ratio, mono-microbial nature or polymicrobial
nature of the infection, type of procedure (single- or two-
stage revision), follow-up, and the presence of comorbidities.
Conversely, there were more methicillin-resistant infections
in the CoNS group (43 versus 15 cases, P\0.05) (Table 2).
The diagnosis of PJI was based on:
1. At least three positive samples (three intraoperative
samples or two intraoperative samples ? one joint
aspiration sample taken a few days before surgery)
identifying a bacterium from the skin flora (e.g., CoNS,
Propionibacterium acnes, Corynebacterium spp., etc.)
that may have resulted from skin contamination during
sample collection.
2. At least one positive sample (one joint aspiration
sample or one intraoperative or blood culture sample)
identifying a bacterium that is not part of the skin flora
and, therefore, cannot be attributed to skin contamina-
tion (SA, Enterobacter spp., Pseudomonas aeruginosa,
etc.).
3. The presence of a rare bacterium that cannot be
attributed to skin contamination (e.g., Streptococcus
pneumoniae, Salmonella, Listeria, Campylobacter,
Pasteurella, etc.).
Sample size calculation
For a 70 % healing rate and detectable difference of 25 %
(5 % alpha risk and 80 % beta risk), at least 80 patients
were needed in the study.
Assessment method
The only healing criterion used was the lack of surgical
revision at the last follow-up. If there was a potential
recurrence of the infection, the patient underwent addi-
tional testing, such as joint aspiration or surgical biopsy,
if needed. Failure was defined as a new surgical proce-
dure being carried out or a pharmaceutical treatment
being provided (suppressive antibiotic therapy) during
the treatment period. Demographics, comorbidities,
surgical parameters, and laboratory test results were also
analysed. Patients were reviewed regularly after the end
of antibiotics therapy at day 45, day 90, 6 months,
1 year, and then annually for 5 years with laboratory
tests (CRP, CBC), clinical examination, and X-rays
being performed.
Table 1 Types of microorganisms found in the coagulate-negative
Staphylococci group







Statistical tests were carried out with the StatView software
(SAS Institute Inc, Cary, NC, USA). Nominal variables
were reported using the number of patients and percent-
ages. Continuous variables were described using the mean,
standard deviation, and maximum and minimum values.
The normal distribution of the variables was verified with
the Shapiro–Wilk test. The two groups were compared
using the parametric test (Student’s independent t test) if
the data were normally distributed and a non-parametric
test (Mann–Whitney) if they were not. Significance
threshold was set at P\ 0.05.
Results
With a minimum follow-up of 24 months and an average
follow-up of 32 ± 8 months, the healing rate of the overall
cohort was 70.3 % (71 of 101 cases). The SA group had a
75 % healing rate (24 of 32 cases) and the CoNS had a
68.1 % healing rate (47 of 69 cases) (P = 0.42). After
excluding patients with polymicrobial infections, these
rates were still similar: 80 % for the SA group (16 of 20
cases) versus 72 % for the CoNS group (39 of 54 cases)
(P = 0.17).
In the patients with SA infection, the healing rate was
76.5 % (13 of 17 cases) in the methicillin-susceptible
group versus 73.3 % (11 of 15 cases) in the methicillin-
resistant group (P = 0.2). In the patients with CoNS
infection, the healing rate was 73 % (19 of 26 cases) in the
methicillin-susceptible group versus 65.1 % (28 of 43
cases) in the methicillin-resistant group (P = 0.14).
Discussion
Our initial hypothesis was not confirmed: the healing rate of
Staphylococcus aureus PJIs was not lower than that of coag-
ulate-negative Staphylococci infections. The polymicrobial
nature of the infection or methicillin resistance did not impact
these findings.
This study has several limitations. Other than its retro-
spective nature, our decision to use a healing endpoint
based on the absence of surgical revision at the last follow-
up visit can be criticised. All the same, failure of surgical
treatment for PJI leading to repeated surgical or pharma-
ceutical treatment corresponds to our failure criteria.
Moreover, the term ‘healing rate’ for PJIs must be used
carefully; the term ‘remission’ used in cancer studies
would likely be more appropriate. This study’s statistical
power was low, thus there is 20 % possibility that we
concluded incorrectly that there was no difference. A
minimum 24-month follow-up is typically used in pub-
lished studies evaluating PJI treatment outcomes [16–19].
The inclusion of polymicrobial infections, which made up
of one-third of cases, is consistent with published studies
[20, 21], but may be a confounding factor for the analysis.
This constitutes a risk factor for treatment failure [22], but
in our study, the proportion of polymicrobial infections was
comparable in the two groups; removing these infections
from the study cohort did not alter the results. Finally,
inclusion of both THA and TKA infections is a con-
founding factor, although the proportion of each was
comparable in the two groups.
This is the first published study to compare the result of
revisions for PJI due to different Staphylococcus species.
Various studies have analysed the healing rate based on the
type of procedure (single- or two-phase revision), antibiotic
therapy, type of surgical procedure (conservative or revi-
sion), and resistant or susceptible nature of the microor-
ganism [1, 9, 18, 23–31]. Vielpeau et al. [32] reviewed 535
cases of revision for THA infection, but found no evidence
that the healing rate varied as a function of Staphylococcus
species. They found 121 cases of SA infection with an
82 % healing rate and 136 cases of CoNS infection with an
84 % healing rate (P[ 0.05). Similarly, Parvizi et al. [1]
did a study of 127 THA and TKA revisions for infection,
but found no evidence of differences in the healing rate for
SA infections (37 cases, 67 % healing rate) or CoNS
Table 2 Characteristics of the
patients in the Staphylococcus
aureus and coagulase-negative
Staphylococci groups
S. aureus (32 cases) Coag-neg S. (69 cases) P
Mean age 63.2 years (78–43) 64.7 years (84–46) n/s
Gender ratio (M/F) 19 M/13 F (1.46:1) 37 M/32 F (1.16:1) n/s
THA/TKA distribution 23/32 (70 %) 48/69 (71 %) n/s
Average follow-up 2.9 years (2–5) 2.6 years (2–5) n/s
Two-stage procedure 22 cases (68 %) 43 cases (62.3 %) n/s
Methicillin resistance 15/32 (46.8 %) 43/69 (62.3 %) \0.05
Healing rate 24 cases (75 %) 47 cases (68.1 %) n/s
Frequency of comorbidities 10/32 (31 %) 22/54 (41 %) n/s
Rate of polymicrobial infections 12/32 (37.5 %) 15/54 (28 %) n/s
infections (35 cases, 68 % infection rate). Tornero el al.
[33] also evaluated the healing rate after conservative
surgical treatment (lavage, debridement) of THA and TKA
infections; they found no differences between the two
microorganisms.
Other studies focused on the healing rate by the type of
microorganism. Joulie et al. [9] analysed the healing rate of
SA infections in a cohort of 95 THA and TKA cases with a
minimum 12-month follow-up. The healing rate was 81 %
overall, with the resistant or susceptible nature of the
microorganisms having no impact, as we found in our
study. This finding is not universal; however, Salgado et al.
[31] showed that the presence of methicillin-resistant SA
was a risk factor for failure.
Conclusion
The healing rate of PJIs due to SA is not lower than that of
PJIs due to CoNS. This suggests that CoNS must be treated
with the same degree of rigour, especially because the
emergence of strains with reduced glycopeptide sensitivity
mainly pertains to CoNS [34, 35].
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